$HELE
HELEN OF TROY LTD Stock $hele

$hele Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000091678923000033 Filed on July 10, 2023

Income Statement

Concept	2023 Q2
Revenue	$474.7M
YoY Change	-6.57%
Cost Of Revenue	$259.0M
YoY Change	-12.75%
Gross Profit	$215.6M
YoY Change	2.11%
Gross Profit Margin	45.43%
Selling, General & Admin	$160.3M
YoY Change	-9.56%
% of Gross Profit	74.33%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$10.72M
YoY Change	2.07%
% of Gross Profit	4.97%
Operating Expenses	$164.9M
YoY Change	-6.94%
Operating Profit	$50.70M
YoY Change	49.37%
Interest Expense	-$14.05M
YoY Change	-421.34%
% of Operating Profit	-27.72%
Other Income/Expense, Net	$137.0K
YoY Change	104.48%
Pretax Income	$26.73M
YoY Change	-9.81%
Income Tax	$4.145M
% Of Pretax Income	15.51%
Net Earnings	$22.58M
YoY Change	-8.19%
Net Earnings / Revenue	4.76%
Basic Earnings Per Share	$0.94
Diluted Earnings Per Share	$0.94
COMMON SHARES
Basic Shares Outstanding	24.04M shares
Diluted Shares Outstanding	24.13M shares

Balance Sheet

Concept	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$38.87M
YoY Change	-21.08%
Cash & Equivalents	$38.87M
Short-Term Investments
Other Short-Term Assets	$24.46M
YoY Change	-5.82%
Inventory	$433.9M
Prepaid Expenses
Receivables	$349.7M
Other Receivables	$9.118M
Total Short-Term Assets	$856.1M
YoY Change	-27.24%
LONG-TERM ASSETS
Property, Plant & Equipment	$391.6M
YoY Change	39.34%
Goodwill	$1.067B
YoY Change	0.15%
Intangibles	$549.4M
YoY Change	-3.13%
Long-Term Investments
YoY Change
Other Assets	$9.109M
YoY Change	9.02%
Total Long-Term Assets	$2.017B
YoY Change	2.49%
TOTAL ASSETS
Total Short-Term Assets	$856.1M
Total Long-Term Assets	$2.017B
Total Assets	$2.873B
YoY Change	-8.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$226.2M
YoY Change	-30.0%
Accrued Expenses	$138.1M
YoY Change	-44.09%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due	$6.235M
YoY Change	-57.36%
Total Short-Term Liabilities	$440.8M
YoY Change	-26.94%
LONG-TERM LIABILITIES
Long-Term Debt	$830.9M
YoY Change	-23.83%
Other Long-Term Liabilities	$55.42M
YoY Change	264.81%
Total Long-Term Liabilities	$886.3M
YoY Change	-19.87%
TOTAL LIABILITIES
Total Short-Term Liabilities	$440.8M
Total Long-Term Liabilities	$886.3M
Total Liabilities	$1.358B
YoY Change	-24.05%
SHAREHOLDERS EQUITY
Retained Earnings	$1.187B
YoY Change	13.51%
Common Stock	$326.9M
YoY Change	6.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.515B
YoY Change
Total Liabilities & Shareholders Equity	$2.873B
YoY Change	-8.63%

Cashflow Statement

Concept	2023 Q2
OPERATING ACTIVITIES
Net Income	$22.58M
YoY Change	-8.19%
Depreciation, Depletion And Amortization	$10.72M
YoY Change	2.07%
Cash From Operating Activities	$121.1M
YoY Change	-415.02%
INVESTING ACTIVITIES
Capital Expenditures	$11.88M
YoY Change	-115.59%
Acquisitions	$0.00
YoY Change	-100.0%
Other Investing Activities	$246.0K
YoY Change	-100.17%
Cash From Investing Activities	-$11.63M
YoY Change	-94.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$1.563M
YoY Change	-17.74%
Cash From Financing Activities	-99.63M
YoY Change	-135.99%
NET CHANGE
Cash From Operating Activities	121.1M
Cash From Investing Activities	-11.63M
Cash From Financing Activities	-99.63M
Net Change In Cash	9.796M
YoY Change	-38.29%
FREE CASH FLOW
Cash From Operating Activities	$121.1M
Capital Expenditures	$11.88M
Free Cash Flow	$109.2M
YoY Change	189.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Interest Expense InterestExpense	14052000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	4373000	usd
CY2022Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	18224000	usd
CY2022Q2	hele	Stock Issued During Period Value Share Based Compensation Excluding Stock Options And Employee Stock Purchase Program Net Of Tax Effect StockIssuedDuringPeriodValueShareBasedCompensationExcludingStockOptionsAndEmployeeStockPurchaseProgramNetOfTaxEffect	16619000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1356422000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1488811000	usd
CY2023Q2	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	22581000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3715000	usd
CY2023Q2	hele	Stock Issued During Period Value Stock Options Exercised Net Of Tax Effect StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxEffect	212000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2168000	usd
CY2023Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	4446000	usd
CY2023Q2	hele	Stock Issued During Period Value Share Based Compensation Excluding Stock Options And Employee Stock Purchase Program Net Of Tax Effect StockIssuedDuringPeriodValueShareBasedCompensationExcludingStockOptionsAndEmployeeStockPurchaseProgramNetOfTaxEffect	9297000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1514908000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	24595000	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10498000	usd
CY2022Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	253000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2543000	usd
CY2022Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	320000	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	16619000	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2022Q2	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	1336000	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	246000	usd
CY2022Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2023Q2	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	3897000	usd
CY2022Q2	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	614000	usd
CY2023Q2	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-26733000	usd
CY2022Q2	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	14639000	usd
CY2023Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-21572000	usd
CY2022Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	47781000	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1420000	usd
CY2022Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-651000	usd
CY2023Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	656000	usd
CY2022Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	823000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	36644000	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	10027000	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-10734000	usd
CY2022Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-28764000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	28498000	usd
CY2023Q2	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	32204000	usd
CY2023Q1	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	36931000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	54967000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	54028000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	193049000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	200718000	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-3362000	usd
CY2022Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-11205000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	121056000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-38428000	usd
CY2023Q2	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	11877000	usd
CY2022Q2	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	76202000	usd
CY2023Q2	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022Q2	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	148111000	usd
CY2023Q2	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	usd
CY2022Q2	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	1804000	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	246000	usd
CY2022Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11631000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-222509000	usd
CY2023Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	70150000	usd
CY2022Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	447000000	usd
CY2023Q2	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	166150000	usd
CY2022Q2	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	153000000	usd
CY2023Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1563000	usd
CY2022Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1900000	usd
CY2022Q2	hele	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options And Tax Benefits ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAndTaxBenefits	2934000	usd
CY2022Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	18224000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	276810000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	15873000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49254000	usd
CY2022Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	12812000	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2023Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2021Q2	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	44700000	usd
CY2021Q2	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	500000	usd
CY2023Q2	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We have reclassified or combined certain amounts in the prior year's accompanying footnotes to conform with the current year's presentation.</span></div>
CY2022Q2	hele	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Income Taxes Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIncomeTaxesPayable	2572000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	23525000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	17380000	usd
CY2023Q2	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	52473000	usd
CY2023Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	63881000	usd
CY2023Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	29880000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	8656000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	15535000	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y1M6D
CY2023Q2	hele	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Target Achievement As A Percentage ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTargetAchievementAsAPercentage	0
CY2021Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	500000000	usd
CY2021Q3	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P3Y
CY2023Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	399200000	usd
CY2023Q2	us-gaap	Insurance Settlements Receivable InsuranceSettlementsReceivable	46000000	usd
CY2023Q1	us-gaap	Insured Event Gain Loss InsuredEventGainLoss	9700000	usd
CY2023Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2155000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2463000	usd
CY2023Q2	hele	Long Term Debt Less Unamortized Prepaid Financing Fees LongTermDebtLessUnamortizedPrepaidFinancingFees	837157000	usd
CY2023Q1	hele	Long Term Debt Less Unamortized Prepaid Financing Fees LongTermDebtLessUnamortizedPrepaidFinancingFees	934412000	usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	6235000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	6064000	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	830922000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	928348000	usd
CY2023Q2	us-gaap	Interest Costs Incurred InterestCostsIncurred	14900000	usd
CY2022Q2	us-gaap	Interest Costs Incurred InterestCostsIncurred	5100000	usd
CY2023Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	900000	usd
CY2022Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	700000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	-3101000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	4525000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	1745000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	516000	usd
CY2023Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-24000	usd
CY2022Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	875000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	4525000	usd
CY2022Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	516000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	850000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3159000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-3101000	usd
CY2023Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	1745000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	-1131000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3715000	usd
CY2023Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	474672000	usd
CY2023Q2	us-gaap	Restructuring Charges RestructuringCharges	7355000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	40641000	usd
CY2023Q2	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	11877000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10715000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	508078000	usd
CY2022Q2	us-gaap	Restructuring Charges RestructuringCharges	2000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	33939000	usd
CY2022Q2	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	76202000	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10498000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	474672000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	508078000	usd
CY2023Q2	hele	Income Tax Expense Benefit Percentage Of Income Before Income Taxes IncomeTaxExpenseBenefitPercentageOfIncomeBeforeIncomeTaxes	0.155
CY2022Q2	hele	Income Tax Expense Benefit Percentage Of Income Before Income Taxes IncomeTaxExpenseBenefitPercentageOfIncomeBeforeIncomeTaxes	0.170
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24049000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23865000	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	85000	shares
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	257000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24134000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24122000	shares

Files In Submission

Name	View Source	Status
0000916789-23-000033-index-headers.html	Edgar Link	pending
0000916789-23-000033-index.html	Edgar Link	pending
0000916789-23-000033.txt	Edgar Link	pending
0000916789-23-000033-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fy24_q1xexhibit311.htm	Edgar Link	pending
fy24_q1xexhibit312.htm	Edgar Link	pending
fy24_q1xexhibit32.htm	Edgar Link	pending
hele-20230531.htm	Edgar Link	pending
hele-20230531.xsd	Edgar Link	pending
hele-20230531_g1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
hele-20230531_def.xml	Edgar Link	unprocessable
hele-20230531_lab.xml	Edgar Link	unprocessable
hele-20230531_pre.xml	Edgar Link	unprocessable
hele-20230531_htm.xml	Edgar Link	completed
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
hele-20230531_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HELE
HELEN OF TROY LTD Stock $hele

2023 Q2 Form 10-Q Financial Statement

#000091678923000033 Filed on July 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HELE HELEN OF TROY LTD Stock $hele

2023 Q2 Form 10-Q Financial Statement

#000091678923000033 Filed on July 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HELE
HELEN OF TROY LTD Stock $hele